Minutia

Minutia is a biotech company in Oakland, United States, founded in 2021. It has raised $15.9M across 5 rounds, most recently a $325K Grant in July 2024.

A Next Generation Cell Therapy Company

Employees
1–10
Founded
2021
Business Model
B2B
Website
minutia.co
Total Funding
$15.9M
Last Round
$325K GrantJul 2024
Rounds
5

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 5 funding rounds and 1 investor for this company. The full record is or through the API.

About

Minutia is a next-generation cell therapy company working towards a functional cure for type 1 diabetes through a transplant of insulin-producing cells combined with nanosensors. The company's novel approach combines robust and controlled insulin-producing cell transplants with in vivo monitoring capability using a unique nanoparticle platform, aiming to revolutionize the clinical landscape for diabetes and cell replacement therapy. Founded by CEO Katy Digovich, who has lived with type 1 diabetes for over 30 years, Minutia is supported by non-dilutive funding from the NIH, California Institute for Regenerative Medicine (CIRM), and JDRF, and is backed by SOSV via an IndieBio cohort.

Summary

It lists 1–10 employees. It has raised $15.9M in total across 5 rounds, most recently a $325K Grant round in Jul 2024. Investors include SOSV.

Funding History

Data from Indexed.vcUpdated
GrantSBIR Phase I (NIH)Jul 2024
$325K

Sign up to see all 5 events

Funding: SAFE through Grant. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Minutia on Indexed.vc
<a href="https://indexed.vc/companies/minutia"><img src="https://indexed.vc/api/badge/company/minutia" alt="Minutia on Indexed.vc" width="260" height="76" /></a>